Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 21559368)

1.

Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer.

Tseng CH, Murray KD, Jou MF, Hsu SM, Cheng HJ, Huang PH.

PLoS One. 2011 Apr 29;6(4):e19396. doi: 10.1371/journal.pone.0019396.

2.

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.

Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.

J Clin Invest. 2010 Aug;120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano [corrected to Mazzone, Massimiliano].

3.

p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.

Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS.

Cancer Res. 2008 Aug 15;68(16):6524-32. doi: 10.1158/0008-5472.CAN-07-6302.

4.

Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.

Bagnato A, Rosanò L.

Cells Tissues Organs. 2007;185(1-3):85-94. Review.

PMID:
17587812
5.

Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.

Sakurai A, Jian X, Lee CJ, Manavski Y, Chavakis E, Donaldson J, Randazzo PA, Gutkind JS.

J Biol Chem. 2011 Sep 30;286(39):34335-45. doi: 10.1074/jbc.M111.259499. Epub 2011 Jul 27.

6.

Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.

Kim J, Oh WJ, Gaiano N, Yoshida Y, Gu C.

Genes Dev. 2011 Jul 1;25(13):1399-411. doi: 10.1101/gad.2042011.

7.

Semaphorin 3E, an exception to the rule.

Klagsbrun M, Shimizu A.

J Clin Invest. 2010 Aug;120(8):2658-60. doi: 10.1172/JCI44110. Epub 2010 Jul 26.

8.

Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.

Christensen C, Ambartsumian N, Gilestro G, Thomsen B, Comoglio P, Tamagnone L, Guldberg P, Lukanidin E.

Cancer Res. 2005 Jul 15;65(14):6167-77.

9.

Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.

Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A.

Cancer Res. 2005 Dec 15;65(24):11649-57.

10.

Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.

Roodink I, Kats G, van Kempen L, Grunberg M, Maass C, Verrijp K, Raats J, Leenders W.

Am J Pathol. 2008 Dec;173(6):1873-81. doi: 10.2353/ajpath.2008.080136. Epub 2008 Oct 30.

11.

Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.

Aghajanian H, Choi C, Ho VC, Gupta M, Singh MK, Epstein JA.

J Biol Chem. 2014 Jun 27;289(26):17971-9. doi: 10.1074/jbc.M113.544833. Epub 2014 May 13.

12.

Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers.

Luchino J, Hocine M, Amoureux MC, Gibert B, Bernet A, Royet A, Treilleux I, Lécine P, Borg JP, Mehlen P, Chauvet S, Mann F.

Cancer Cell. 2013 Nov 11;24(5):673-85. doi: 10.1016/j.ccr.2013.09.010. Epub 2013 Oct 17.

13.

Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis.

Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C, Rivard N.

Int J Cancer. 2009 Oct 1;125(7):1575-86. doi: 10.1002/ijc.24485.

PMID:
19462441
14.

Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.

Joseph D, Ho SM, Syed V.

Mol Cancer Ther. 2010 Feb;9(2):499-509. doi: 10.1158/1535-7163.MCT-09-0664. Epub 2010 Feb 2.

15.

Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.

Usami Y, Satake S, Nakayama F, Matsumoto M, Ohnuma K, Komori T, Semba S, Ito A, Yokozaki H.

J Pathol. 2008 Jul;215(3):330-9. doi: 10.1002/path.2365.

PMID:
18491351
16.

EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?

Cheng JC, Auersperg N, Leung PC.

PLoS One. 2012;7(3):e34071. doi: 10.1371/journal.pone.0034071. Epub 2012 Mar 30.

17.

HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.

Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A.

J Biol Chem. 2008 Nov 28;283(48):33437-46. doi: 10.1074/jbc.M802016200. Epub 2008 Oct 1.

18.

Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation.

Lee MY, Chou CY, Tang MJ, Shen MR.

Clin Cancer Res. 2008 Aug 1;14(15):4743-50. doi: 10.1158/1078-0432.CCR-08-0234.

19.

Epithelial-mesenchymal transition and the invasive potential of tumors.

Gavert N, Ben-Ze'ev A.

Trends Mol Med. 2008 May;14(5):199-209. doi: 10.1016/j.molmed.2008.03.004. Epub 2008 Apr 10.

PMID:
18406208
20.

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, Giraudo E, Mazzone M, Neufeld G, Tamagnone L.

EMBO Mol Med. 2012 Mar;4(3):234-50. doi: 10.1002/emmm.201100205. Epub 2012 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk